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Juvenile polyposis coli (JPC) is a rare hereditary disorder in which patients have multiple polyps in the
gastrointestinal tract and present most commonly with hematochezia. We describe a 4-year-old with
intermittent rectal prolapse presenting with altered mental status and headaches. JPC was diagnosed by
the presence of multiple, pedunculated, colonic polyps on colonoscopy; his altered mental status
resulted from cerebral venous sinus thrombosis. Although JPC is known to be associated with a protein
losing enteropathy (PLE), this usually manifests as merely hypoalbuminemia and protein losses without
major clinical sequelae. We present a rare complication of cerebral venous sinus thrombosis which
highlights altered mental status as a rare presentation of JPC. To our knowledge, this is the ﬁrst case
report in the literature linking JPC, decreased protein S activity, a single mutation in the methylenete-
trahydrofolate reductase gene and cerebral thrombosis.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Colorectal polyps are the most common tumors of the colon
and rectum in childhood. A retrospective review of 487 children
in China reveals hematochezia to be the most common presen-
tation. 8.8% of the cohort presented with rectal prolapse. Inter-
estingly, rectal polyps can be misdiagnosed as intermittent rectal
prolapse, and solitary juvenile polyps (88.4%) were the most
common cause. Moreover, 3% of these patients presented with
juvenile polyposis syndrome (JPS) [1]. JPS is a rare, autosomal
dominant hereditary disorder occurring in 1:16000e1:100,000 of
the population [2]. It has been categorized into three subsets. One
subset is juvenile polyposis of infancy, which occurs in the ﬁrst
two years of life with multiple polyps throughout the gastroin-
testinal tract. This is the most severe form and is associated with
early death. These patients develop a protein losing enteropathy
with severe diarrhea, cachexia, failure to thrive and
hypoproteinemia. Generalized JPS and juvenile polyposis coli
(JPC) are the two other subsets. These both occur later in the ﬁrst
two decades of life, but they can be differentiated by theiversity of Maryland Medical
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Inc. This is an open access article udistribution of the polyps. Generalized JPS presents with polyps
throughout the gastrointestinal tract, while JPC is limited to the
colon [3].
JPC can present with a variety of symptoms; although severe
hematochezia is the most common, JPC can also present with
anemia, persistent abdominal pain, tenesmus, diarrhea, hypo-
protenemia, malnutrition, intestinal obstruction and rectal pro-
lapse. As mentioned earlier, severe protein losing enteropathy
(PLE) with hypoproteinemia, cachexia and failure to thrive may
develop. These patients will often be found to have digital club-
bing [3,4]. We describe a patient with a rare presentation
of altered mental status secondary to his protein losing
enteropathy.
1. Case presentation
A 4-year-old African American boy with a two-year history of
constipation and asthma and a one-year history of intermittent
headaches was being evaluated for suspected intermittent rectal
prolapse. On presentation he was noted to have malnutrition with
an albumin of 1.5 g/dl. He was in the 25th percentile for weight and
possessed clubbing of his digits on physical examination. One day
after his outpatient visit, he returned with recurrent emesis,
dehydration and altered mental status with lethargy and head-
aches. A head CT demonstrated a dural venous sinus thrombosis ofnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. MRV demonstrating absent ﬂow in the vein of Galen, straight, superior sagittal
and proximal transverse sinuses with prominent draining veins consistent with cere-
bral venous sinus thrombosis.
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conﬁrmed by MRI/MRV (Fig. 1). Further workup shown in Table 1
revealed protein S activity deﬁciency of 53% (normal range of
60e145%), believed to be secondary to malabsorption and a single
methylenetetrahydrofolate reductase (MTHFR) mutation, A1298C,
without a C677T mutation. This single A1298C mutation is not
associated with elevated homocysteine levels, which are associated
with thrombosis [2]. Indeed, our patient had a normal homocys-
teine level of 4.3 (0e15 umol/L). The remainder of the hypercoag-
ulable workup was negative.
No signiﬁcant cardiac abnormalities were uncovered. Family
historywas negative as was cystic ﬁbrosis genetic testing. A positive
calprotectin of >1250 ug/g (normal range of 0e120 ug/g) demon-
strated signs of an inﬂammatory process without infection.
Esophagogastroduodenoscopy revealed hemorrhagic gastritis and
erosive esophagitis, but no polyps. Capsule endoscopy also found no
polyps in the remaining small bowel. A ﬂexible sigmoidoscopy
uncovered more than 20 pedunculated and sessile polyps rangingTable 1




Homocysteine 4.3 0e15 umol/L
Anticardiolipin IgA <9 0e12
Anticardiolipin IgM <9 0e14
Anticardiolipin IgM <9 0e11
AT III Activity 131 75e135%
Factor V Leiden mutation Negative
Factor V activity 98 60e140%
Factor II DNA mutation Negative
Protein S activity 51 67e136%
Post-colectomy
Protein S total 123 58e150
Protein S free 91 56e124%
Protein C activity 110 74e151%
Protein C level 106 70e140%
Vitamin B12 653 180e914 pg/mLfrom 2 to 25 mms with submucosal hemorrhage in the recto-sig-
moid junction (Fig. 2).
The patient was found to have protein losing enteropathy with
a stool content of a-1 antitrypsin of >1.33 (0.00e0.62). Initially,
the patient was treated medically with total parental nutrition,
albumin infusion and octreotide for 7 days. His mental status and
lethargy improved four days after starting anticoagulation.
Despite stopping his anticoagulation therapy, he continued to
have hematochezia and was unable to remain off anticoagulation
due to worsening headaches and clot burden; his symptoms
resolved within three days of restarting his anticoagulation ther-
apy. Two weeks later, following successful anticoagulation therapy
for his sinus thrombosis with decreasing thrombus density on a
head CT, he underwent an urgent subtotal colectomy with end
ileostomy (Fig. 3A). The deﬁnitive pull-through procedure was not
done at this initial surgery due to his poor nutritional status,
which could not be reversed by total parenteral nutrition with his
colon in-situ.
Histological analyses conﬁrmed the diagnosis of JPC (Fig. 3B).
MRI two months later demonstrated complete resolution of his
cerebral venous sinus thrombosis. Further hypercoagulable
workup revealed a normal protein S and C levels. Following his
colectomy, the patient was taken off total parental nutrition with a
calorie count demonstrating his ability to maintain adequate
enteral nutrition. The patient represented 6 months later with a
normal nutritional status; at which time, he underwent a Soave
endorectal ileoanal pull-through procedure with ileostomy
closure.
He has since undergone annual endoscopic evaluations without
evidence of recurrent polyps, as well as annual radiographic im-
aging of the brain without evidence of a recurrent dural venous
sinus thrombosis. Three years after his initial surgery, the patient is
doing well, with a normal appetite, three to ﬁve bowel movements
per day, and normal weight gain and development without clinical
or radiographic neurological sequel.
2. Discussion
Protein losing enteropathy is uncommon in JPC; rather, it is
usually found in juvenile polyposis of infancy. Our patient pre-
sented with a rare complication of protein losing enteropathy in
JPC, symptomatic cerebral venous sinus thrombosis related to
protein S deﬁciency. Protein losing enteropathy is caused by pro-
tein leakage through the gastrointestinal mucosa resulting in
decreased serum protein levels. Protein losing enteropathy is
either a result of lymphatic dilation with rupture and leakage of
protein-rich lymphatic ﬂuid; venous hypertension impairing
mesenteric ﬂow or pathology causing increased cell permeability,
loss of villi or mucosal erosions. Known causes include primary
intestinal lymphagectesia (PIL) due to congenital lymphatic mal-
formation, venous hypertension due to congestive heart failure,
pericarditis, status post a Fontan procedure, lymphoma and
mucosal erosions in infectious gastroenteritis or inﬂammatory
bowel disease [5].
Hypoproteinemia in protein losing enteropathy typically im-
pacts proteins with a slow turnover rate like albumin, immuno-
globulin and ﬁbrinogen. There is a compensatory increase in
hepatic production; however, up to 60% of the enteric albumin
pool is lost causing decreased oncotic pressures with resulting
edema, ascites, pleural and pericardial effusion [5]. Although
protein losing enteropathy results in hypoalbuminemia and causes
edema, other protein losses rarely have shown to be of clinical
signiﬁcance.
Exceptions to this include patients with primary intestinal
lymphagectesia and patients with depletion of clotting factors, as in
Fig. 2. Sigmoidoscopy demonstrating >20 pedunculated and sessile polyps in the colon ranging from 2 to 25 mm, with submucosal hemorrhages, extending from the rectum to
30 cm from the anus.
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humoral and cellular immunity defects with the loss of lympho-
cytes and immunoglobulins, especially IgG2 and CD3. This immune
compromise along with hypoproteinemia impairs villi regeneration
and mucosal repair, thereby, acting as a portal for pathogens
resulting in high morbidity and mortality in immunocompromised
patients [6]. The loss of clotting factors through the gastrointestinal
tract in protein losing enteropathy has rarely been demonstrated to
have clinical sequelae [7]. Case reports have shown anti-thrombin
III and protein S deﬁciency from protein losing enteropathy causing
ischemic strokes [8]. Furthermore, a Canadian registry of 171 pa-
tients with venous thromboembolism only demonstrated 1.2% with
protein S deﬁciency [9]. Our patient with protein losing enteropa-
thy had a single mutation of the MTHFR gene, which by itself does
not lead to thrombosis [10]. Protein S deﬁciency has three different
types of which type II is associated with normal protein S levels
with altered activity secondary to mutations, while acquired is
associated with altered free levels and activity.
We hypothesize that in addition to the MTHFR gene mutation,
additional insult of malabsorptionwith decreased Protein S activity
led to his cerebral venous sinus thrombosis, which clinically man-
ifested as symptoms of lethargy and headaches. As protein S levels
were not tested prior to the colectomy/malnutrition phase we are
only able to speculate that the cerebral venous thrombosis is due to
protein S activity decrease due to protein S deﬁciency or loss of a
different protein from the GI tract. To our knowledge, this is the ﬁrst
case report in the literature linking JPC, decreased protein S activity,
a single mutation in the MTHFR gene and cerebral thrombosis [11].
Traditionally protein losing enteropathy was diagnosed with the
presence of fecal alpha-1 antitrypsin as in our patient. Recently,
diagnosis with technetium 99m HAS scintigraphy demonstrated
100% sensitivity in a study of 13 patients compared to 46% using the
standard alpha-1 antitrypsin clearance [12]. Initial management of
protein losing enteropathy consists of providing nutritional supportFig. 3. A: Gross anatomical analysis of the subtotal colectomy displayed numerous juvenil
polyps demonstrated cystic dilation of glands with smooth lining and rounded contours ofwith a high protein diet of greater than 2 g/kg/day to bypass the
damaged lymphatics. Intravenous infusion of albumin increases
oncotic pressure and decreases edema, but it is of limited beneﬁt in
light of the ongoing protein loss. Adjuvant therapy includes sub-
cutaneous heparin to improve the mechanical gut barrier by
decreasing microthrombi to the mesenteric vessels and inﬂam-
mation. Budesonide, a speciﬁc enteric steroid, has been shown to
increase albumin levels, and octreotide, a somatostatin analogue,
decreases lymphatic ﬂow. Protein losing enteropathy associated
with Fontan procedure can be reversed with surgical correction of
the obstruction [13].
Patients with JPC complicated by protein losing enteropathy
have two surgical options: a subtotal colectomy with ileorectal
anastomosis versus a total proctocolectomy with ileoanal anasto-
mosis with or without a pouch. In a study of 13 patients, 9 patients
underwent the former option; whereas, 4 had the latter. More then
50% of the patients from the ﬁrst cohort underwent a proctoco-
lectomy at a median of 9 years from their initial surgery [4]. Our
patient was initially treated with total parental nutrition, albumin
infusion and octreotide; however, due to his refractory protein
losing enteropathy, malnutrition, hematochezia and inability to
remain off his anticoagulation, he was initially diverted with an end
ileostomy and underwent a subtotal colectomy. This served as a
temporizing measure, thus allowing the patient to improve his
nutritional status before receiving the deﬁnitive surgery.3. Conclusion
Although protein losing enteropathy is typically associated with
hypoalbuminemia without major clinical sequelae, we present a
rare complication of protein losing enteropathy: and cerebral
venous sinus thrombosis that can be speculated to be associated
with protein S deﬁciency. This case report highlights altered mentale polyps with granulation tissue and hemorrhage. B: H&E histological staining of the
the cysts.
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